Guardant Health (GH)
Blood and tissue cancer tests spanning screening, monitoring, and treatment selection.
$177.59
vs last close+0.43 (+0.24%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
in 35 days
EPS estimate
−$0.29
Revenue estimate
$350.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26May '26Jul '26Oct '26
Reported−$0.90−$0.77−$0.80−$0.74−$1.00−$0.85−$0.90Pending
Estimate−$0.75−$0.78−$0.74−$0.79−$0.77−$0.81−$0.76−$0.29
Surprise−20.0%+1.3%−8.0%+6.3%−30.4%−5.5%−18.1%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26May '26Jul '26Oct '26
Reported$201.8M$203.5M$232.1M$265.2M$281.3M$301.7M$335.0MPending
Estimate$192.1M$190.1M$211.5M$235.6M$272.4M$279.2M$314.2M$350.8M
Surprise+5.0%+7.0%+9.7%+12.6%+3.2%+8.1%+6.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.37 | — | — |
| Sep 2028 | $0.16 | — | — |
| Jun 2028 | −$0.02 | — | — |
| Mar 2028 | −$0.23 | — | — |
| Dec 2027 | −$0.39 | — | — |
| Sep 2027 | −$0.43 | — | — |
| Jun 2027 | −$0.62 | — | — |
| Mar 2027 | −$0.72 | — | — |
| Dec 2026 | −$0.74 | — | — |
| Oct 2026 | −$0.29 | — | — |
| Jul 2026 | −$0.76 | −$0.90 | −18.1% |
| May 2026 | −$0.81 | −$0.85 | −5.5% |
| Feb 2026 | −$0.77 | −$1.00 | −30.4% |
| Oct 2025 | −$0.79 | −$0.74 | +6.3% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.37 | — | — | $595.1M | — | — | — |
| Sep 2028 | $0.16 | — | — | $621.2M | — | — | — |
| Jun 2028 | −$0.02 | — | — | $589.3M | — | — | — |
| Mar 2028 | −$0.23 | — | — | $521.9M | — | — | — |
| Dec 2027 | −$0.39 | — | — | $510.7M | — | — | — |
| Sep 2027 | −$0.43 | — | — | $480.1M | — | — | — |
| Jun 2027 | −$0.62 | — | — | $440.9M | — | — | — |
| Mar 2027 | −$0.72 | — | — | $392.7M | — | — | — |
| Dec 2026 | −$0.74 | — | — | $368.6M | — | — | — |
| Oct 28, 2026 | −$0.29 | — | — | $350.8M | — | — | — |
| Jul 30, 2026 | −$0.76 | −$0.90 | −18.1% | $314.2M | $335.0M | +6.6% | +6.3% |
| May 7, 2026 | −$0.81 | −$0.85 | −5.5% | $279.2M | $301.7M | +8.1% | +3.7% |
| Feb 19, 2026 | −$0.77 | −$1.00 | −30.4% | $272.4M | $281.3M | +3.2% | −3.1% |
| Oct 29, 2025 | −$0.79 | −$0.74 | +6.3% | $235.6M | $265.2M | +12.6% | +27.9% |
| Jul 30, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Feb 20, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 24, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 12, 2019 | |||||||
| Nov 19, 2018 | |||||||
| Oct 5, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |